Product description

Fields of Application: Parkinson's disease. Carbidopa, an aromatic L-amino acid decarboxylase inhibitor, which does not cross the blood-brain barrier, is routinely administered in combination with levodopa to patients with Parkinson’s disease to reduce the peripheral decarboxylation of levodopa to dopamine.
Read more


Model CEP, DMF
Categories APIs
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Switzerland
Measured In Pieces
Selling Points Brand Name; Experienced Technicians; International Approvals/Standards; Place of Origin; Prompt Delivery; Quality Service; Reputation
Show more specifications

More products from Bachem AG

View all our products (24)

Products from other suppliers